​FDA Program Gives Patients Faster Access to Breakthrough Medical Technologies

In 2016, the FDA initiated the Breakthrough Device Program with the purpose of bringing new and innovative medical technologies to market faster in order to improve patient treatments and experiences. The program modernizes the medical device approval process and expands the agency’s Expedited Access Pathways (EAP) program. Already the Breakthrough Device Program is starting to show promise in helping innovators develop more effective tools to treat and diagnose life-threatening or irreversibly debilitating diseases.

EAP ELIGIBILITY

As part of the EAP, the Breakthrough Device provision is an enhanced approach to the traditional 510(k) clearance process, and leverages modern, science-based, consensus standards and FDA-developed performance criteria in evaluating new devices for safety and effectiveness. This streamlined process is intended for technologies, for which either no approved or cleared treatment exists, or that offer significant advantages over approved alternatives. These advantages may include reducing or eliminating the need for hospitalization, improving patient quality of life, facilitating patients’ ability to manage their own care (such as through self-directed personal assistance), or establishing long-term clinical efficiencies. A device can also win EAP designation by showing that its availability is in the best interest of patients.¹

PROGRAM IMPACT ON PUBLIC HEALTH

The FDA implemented the EAP in April 2015, and so far, the initiative has achieved significant benefits. In 2016, the agency approved 91 innovative devices, nearly 4 times the number in 2009.² It is expected that 2018 will set a record for new device approvals as well. According to the FDA, there has been an increase in high quality, safe, and effective devices of public health importance approved in the United States as the first commercial market.

BENEFITS OF BEING FIRST

Arriving first to market is a win for patients in the U.S., allowing them early access to important medical technologies, such as the first artificial pancreas. In the future, U.S. consumers may be the first in the world to experience the Orion Cortical Visual Prosthesis System, a brain implant for patients with blindness due to optic nerve damage. As an EAP designated technology, the Orion from Second Sight Medical Products Inc. qualified for interactive communication with the FDA even before clinical trials began. The early engagement allowed for the development of a flexible study design, and a more efficient process for evaluating the technology. The FDA was able to expeditiously measure benefits and risks of the device, clearing the way for a small clinical trial as part of the overall approval process.³

At Sunrise Labs, we develop solutions to improve healthcare by innovating advanced medical devices and engineering breakthrough technologies. Our ISO-13485:2016 certified processes ensure that our work will comply with regulatory bodies worldwide. By leveraging our extensive experience, we solve design challenges and create robust solutions for our clients. Visit our product development webpage to see the Sunrise approach to launching a new device.

https://www.fda.gov/medicaldevices/deviceregulationandguidance/howtomarketyourdevice/ucm441467.html
https://www.qualitydigest.com/inside/fda-compliance-article/new-steps-facilitate-medical-device-innovation-020618.html
https://www.qualitydigest.com/inside/fda-compliance-article/benefits-fda-s-breakthrough-device-program-032618.html

Follow us on social media for the latest updates in B2B!

Image

Latest

digital solutions
Digital Solutions at the Heart of Energy Transition: ABB’s Strategy for a Greener Tomorrow
March 19, 2024

As the world embarks on a pivotal energy transition, companies like ABB are at the forefront, integrating digital solutions to support this shift. By focusing on sustainability, reliability, and the development of in-country value, ABB is reshaping how the energy sector operates, making it more efficient and adaptable to new challenges such as renewable […]

Read More
data migration
Data Experts to the Rescue! Syniti Navigates Your Utility’s Data Migration Maze with Ease
March 19, 2024

In the rapidly evolving utilities industry, the transition towards modern and efficient data management systems is fraught with challenges, yet essential for scalability and sustainability. As companies strive for modernization, data migration emerges as a critical yet complex task, highlighted by the risk of data loss, the need for stakeholder engagement, and the potential […]

Read More
operational technology
Skydio Pioneers Future of Utility Sector with Groundbreaking Operational Technology
March 18, 2024

The utility industry, at a pivotal moment of transformation, is witnessing a technological renaissance, spearheaded by innovative companies like Skydio. The Skydio X10 drone, a marvel of modern engineering, is revolutionizing how utilities inspect and maintain critical infrastructure, offering unmatched precision and reliability. This advancement is not isolated; it’s part of a broader trend […]

Read More
Chad Newtown of Osmose Utilities Services on utility infrastructure
Creating and Preserving Resilience is Priority for Utility Infrastructure
March 18, 2024

Growing conversations surrounding climate change have also intensified discussions on the frequency and severity of weather-related disasters, and the resilience of utility infrastructures, particularly power grids. As a result, examining the dynamic world of utility infrastructure is increasingly pertinent. This urgency to bolster the structural integrity of the electrical grid cannot be overstated since […]

Read More